MedPage Today on MSNOpinion

Let's rethink how EHRs flag 'abnormal' lab results

Portal designs often amplify alarm rather than offering context ...
eturbonews

New Cardiac Mapping System to Treat Abnormal Heart Rhythms

Abbott today announced it has received clearance from the U.S. Food and Drug Administration for the EnSite™ X EP System with EnSite Omnipolar Technology (OT), a new cardiac mapping platform available ...
Seeking Alpha

Medtronic's extravascular defibrillator system for abnormal heart rhythms gets CE mark

Medtronic (NYSE:MDT) said it received CE (Conformité Européenne) mark for its Aurora EV-ICD MRI SureScan (Extravascular Implantable Cardioverter-Defibrillator) and Epsila EV MRI SureScan ...
Seeking Alpha

Abbott Receives CE Mark for its Volt™ Pulsed Field Ablation System to Treat Patients with Abnormal Heart Rhythms

Abbott (ABT)'s Volt™ PFA System is designed to provide a new therapy option for people battling heart rhythm disorders such as atrial fibrillation Pulsed field ablation – or PFA – uses high energy ...
Nasdaq

Abbott Receives U.S. FDA Clearance for New Cardiac Mapping System to Improve How Doctors Treat Abnormal Heart Rhythms

- EnSite™ X EP System with EnSite Omnipolar Technology (OT) provides a 360-degree view of the heart, regardless of catheter orientation, for cardiac mapping without compromise ABBOTT PARK, Ill., Jan.